ZA879308B - 5-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5 tetrahydropyridazin-3-ones - Google Patents

5-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5 tetrahydropyridazin-3-ones

Info

Publication number
ZA879308B
ZA879308B ZA879308A ZA879308A ZA879308B ZA 879308 B ZA879308 B ZA 879308B ZA 879308 A ZA879308 A ZA 879308A ZA 879308 A ZA879308 A ZA 879308A ZA 879308 B ZA879308 B ZA 879308B
Authority
ZA
South Africa
Prior art keywords
tetrahydropyridazin
benzothiazinyl
benzoxazinyl
ones
Prior art date
Application number
ZA879308A
Other languages
English (en)
Inventor
Donald W Combs
W Combs Donald
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of ZA879308B publication Critical patent/ZA879308B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA879308A 1986-12-22 1987-12-10 5-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5 tetrahydropyridazin-3-ones ZA879308B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/944,316 US4721784A (en) 1986-12-22 1986-12-22 6-benzoxazinyl-2,3,4,5-tetrahydropyridazin-3-ones

Publications (1)

Publication Number Publication Date
ZA879308B true ZA879308B (en) 1989-08-30

Family

ID=25481182

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879308A ZA879308B (en) 1986-12-22 1987-12-10 5-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5 tetrahydropyridazin-3-ones

Country Status (6)

Country Link
US (1) US4721784A (ja)
JP (1) JPS63239284A (ja)
CN (2) CN87108354A (ja)
IE (1) IE873339L (ja)
PH (1) PH26651A (ja)
ZA (1) ZA879308B (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803270A (en) * 1986-03-10 1989-02-07 Sumitomo Chemical Company, Limited Process of producing fluoroaniline derivatives
US4975428A (en) * 1988-05-31 1990-12-04 Iolab Corporation Treatment of glaucoma using phosphodiesterase inhibitors
US5420126A (en) * 1989-11-08 1995-05-30 Yamanouchi Pharmaceutical Co., Ltd. 3,4-dihydro-2H-1,4-benzoxazine derivatives and pharmaceutical compositions containing the same
JP2996475B2 (ja) * 1989-12-22 1999-12-27 サントリー株式会社 ベンズオキサジノン誘導体及びそれを有効成分として含有する除草剤
AU638154B2 (en) * 1990-10-04 1993-06-17 Suntory Limited Benzoxazine derivative and herbicide containing same as an active ingredient
US5116837A (en) * 1990-12-21 1992-05-26 Ortho Pharmaceutical Corporation 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
US5221742A (en) * 1990-12-21 1993-06-22 Ortho Pharmaceutical Corporation Process for the preparation of 6-(3,4-dihydro-3-oxo-1,4(2h)-benzoxazin-7-yl)-2,3,4,5-tetrahydropyridazin-3-ones
AU753576B2 (en) * 1997-12-15 2002-10-24 Altana Pharma Ag Dihydrobenzofurans
CN100471856C (zh) * 2003-07-31 2009-03-25 Irm责任有限公司 作为pdf抑制剂的二环化合物和组合物
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
PE20071164A1 (es) * 2005-12-28 2008-01-11 Takeda Pharmaceutical Compuestos heterociclico fusionado como antagonista del receptor mineralocorticoide
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1991212A1 (en) * 2006-03-08 2008-11-19 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2010502722A (ja) * 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
AU2007299920A1 (en) * 2006-09-19 2008-03-27 Braincells, Inc. PPAR Mediated Modulation of Neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4640707A (en) * 1984-07-23 1987-02-03 Sumitomo Chemical Company, Ltd. Tetrahydrophthalimides and their herbicidal use
US4619687A (en) * 1984-09-27 1986-10-28 Sumitomo Chemical Company, Limited Triazolopyridazines and their use as herbicides

Also Published As

Publication number Publication date
CN1071427A (zh) 1993-04-28
IE873339L (en) 1988-06-22
PH26651A (en) 1992-09-04
JPS63239284A (ja) 1988-10-05
CN87108354A (zh) 1988-09-21
US4721784A (en) 1988-01-26

Similar Documents

Publication Publication Date Title
EG18875A (en) Alpha-aryl-alpha-phenylethyl-1h-1,2,4-triazole-1-propanenitriles
ZA879308B (en) 5-benzoxazinyl-and 6-benzothiazinyl-2,3,4,5 tetrahydropyridazin-3-ones
PT86453A (en) 6-benzoxazinyl- and 6-benzothiazinyl-2,3,4,5-tetrahydropyrudazin-3-ones
ZA874093B (en) Certain 2-phenylacetyl-1,3,5-cyclohexanetriones
ZA87428B (en) Novel 2,4-diamino-6-haloalkylpyrimidines
CS932686A1 (en) Zpusob pripravy 2,6 diaminomesitylen 4 sulfonove kyseliny
CS650086A1 (en) Zpusob pripravy 2,6 dichlordifenylaminu
GB8725002D0 (en) 2,5-disubstituted-7,7,8,8-tetracyanoquinodimethanes
CS393386A1 (en) Sposob pripravy 2,2 dibenztiazolyldisulfidu
CS594886A1 (en) Sposob vyroby derivatov 2,1,3 benzotiadiazin 4 on 2,2 dioxidu
ZW387A1 (en) 1,6-dicarba-polypeptide compounds
GB8602037D0 (en) 3-dimethylamino-7-methyl-1,2,4-benzotriazine-1-oxide
CS748286A1 (en) Zpusob vyroby 3,5 dinitrobenzoove kyseliny
CS647286A1 (en) Sposob vyroby 2,2 sialkoxypropanu
CS361486A1 (en) Zpusob rafinacni kondenzace 9,10 antrachinonu
EP0252389A3 (en) 1,1-dialkoxy-2-methyl-4,4-diacyloxybutenes
CS368686A1 (en) Zpusob pripravy 2,2,6,6 tetrametyl 4 piperidonoximu
GB8602035D0 (en) 3-dimethylamino-7-methyl-1,2,4-benzotriazine-1-oxide
GB8602036D0 (en) 3-dimethylamino-7-methyl-1,2,4-benzotriazine-1-oxide
CS422986A1 (en) Zpusob vyroby kyseliny 2,4,4,4 tetrachlormaselne
GB8602038D0 (en) 3-dimethylamino-7-methyl-1,2,4-benzotriazine-1-oxide
CS475186A1 (en) Zpusob pripravy 2,6 dichlorthiobenzamidu
CS532386A1 (en) Zpusob vyroby 2,4 dinitrofenyl 4 aminodifenylamin 2 sulfonanu sodneho
CS607386A1 (en) Sposob vyroby 2,2 dialkoxypropanu
IE861046L (en) 2,5-diaryltetrahydrofurans